This page includes the latest FDA filings for Swedish Orphan Biovitrum Ab Publ. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.
SWEDEN | STOCKHOLM STOCK EXCHANGE | SOBI | DUNS 354010589 |
Device Company | Device | Date |
---|---|---|
Swedish Orphan Biovitrum AB (publ) | Prescription Medication | 2024-12-22 |
Swedish Orphan Biovitrum AB (publ) | Prescription Medication | 2024-12-15 |
Swedish Orphan Biovitrum AB (publ), Boehringer Ingelheim Pharma GmbH & Co KG (BIP, an affiliate to BI RCV), Germany, Boehringer Ingelheim RCV, Austria, Charles River Laboratories Edinburgh Ltd., UK, Charles River Laboratories Inc. USA, Eurofins Biolab S.r.l., I | Prescription Medication | 2024-11-15 |
Swedish Orphan Biovitrum AB (publ), Patheon Italia S.p.A | Prescription Medication | 2024-10-11 |
Swedish Orphan Biovitrum AB (publ), Patheon Italia S.p.A | Prescription Medication | 2024-08-23 |
Swedish Orphan Biovitrum AB (publ), Patheon Italia S.p.A | Prescription Medication | 2023-09-21 |
Swedish Orphan Biovitrum AB (publ) | Prescription Medication | 2023-08-04 |
Swedish Orphan Biovitrum AB (publ) | Prescription Medication | 2023-02-15 |
Swedish Orphan Biovitrum AB (publ) | Prescription Medication | 2022-07-06 |
SWEDISH ORPHAN BIOVITRUM AB (PUBL), Apotek Produktion & Laboratorier AB | Prescription Medication | 2022-06-12 |
Swedish Orphan Biovitrum AB (publ), Patheon Italia S.p.A | Prescription Medication | 2022-06-08 |
Swedish Orphan Biovitrum AB (publ), Almac Pharma Services LLC, AstraZeneca Nijmegen B.V., AstraZeneca Pharmaceuticals LP, BioReliance Corporation, Boehringer Ingelheim Pharma GmbH and Co., Charles River Laboratories, Inc., Eurofins Lancaster Laboratories, Inc. | Prescription Medication | 2022-03-29 |
Swedish Orphan Biovitrum AB (publ), Almac Pharma Services LLC, AstraZeneca Nijmegen B.V., AstraZeneca Pharmaceuticals LP, BioReliance Corporation, Boehringer Ingelheim Pharma GmbH and Co., Charles River Laboratories, Inc., Eurofins Lancaster Laboratories, Inc. | Prescription Medication | 2021-09-29 |
Swedish Orphan Biovitrum AB (publ) | Prescription Medication | 2021-07-29 |
Swedish Orphan Biovitrum AB (publ), Boehringer Ingelheim Pharma GmbH & Co KG (BIP, an affiliate to BI RCV), Germany, Boehringer Ingelheim RCV, Austria, Charles River Laboratories Edinburgh Ltd., UK, Charles River Laboratories Inc. USA, Eurofins Biolab S.r.l., I | Prescription Medication | 2020-12-30 |
Swedish Orphan Biovitrum AB (publ), Almac Pharma Services LLC, AstraZeneca Nijmegen B.V., AstraZeneca Pharmaceuticals LP, BioReliance Corporation, Boehringer Ingelheim Pharma GmbH and Co., Charles River Laboratories, Inc., Eurofins Lancaster Laboratories, Inc. | Prescription Medication | 2020-12-02 |
Swedish Orphan Biovitrum AB (publ), Patheon Italia S.p.A | Prescription Medication | 2020-07-09 |
Swedish Orphan Biovitrum AB (publ) | GAMIFANT | 2020-06-26 |
Swedish Orphan Biovitrum AB (publ) | Prescription Medication | 2020-04-22 |
Swedish Orphan Biovitrum AB (publ) | Prescription Medication | 2020-01-23 |
SWEDISH ORPHAN BIOVITRUM AB (PUBL), Apotek Produktion & Laboratorier AB | Prescription Medication | 2019-05-29 |
Swedish Orphan Biovitrum AB (publ) | Prescription Medication | 2019-05-29 |
Swedish Orphan Biovitrum AB (publ), Patheon Italia S.p.A | Prescription Medication | 2019-05-18 |
Swedish Orphan Biovitrum AB (publ) | GAMIFANT | 2019-05-17 |
Swedish Orphan Biovitrum AB (publ) | GAMIFANT | 2019-05-17 |
Swedish Orphan Biovitrum AB (publ) | Prescription Medication | 2018-12-19 |
Swedish Orphan Biovitrum AB (publ), Boehringer Ingelheim Pharma GmbH & Co KG (BIP, an affiliate to BI RCV), Germany, Boehringer Ingelheim RCV, Austria, Charles River Laboratories Edinburgh Ltd., UK, Charles River Laboratories Inc. USA, Eurofins Biolab S.r.l., I | Prescription Medication | 2018-08-07 |
SWEDISH ORPHAN BIOVITRUM AB (PUBL) | Orfadin | 2016-07-01 |
SWEDISH ORPHAN BIOVITRUM AB (PUBL) | Orfadin | 2016-07-01 |
SWEDISH ORPHAN BIOVITRUM AB (PUBL) | Orfadin | 2016-07-01 |
SWEDISH ORPHAN BIOVITRUM AB (PUBL) | Orfadin | 2016-07-01 |
Swedish Orphan Biovitrum AB (publ) | ORFADIN | 2016-06-01 |
Swedish Orphan Biovitrum AB (publ) | Kineret | 2009-12-15 |
Swedish Orphan Biovitrum AB (publ) | Kepivance | 2009-12-15 |
Swedish Orphan Biovitrum AB (publ) | Synagis | 1999-12-09 |
Swedish Orphan Biovitrum AB (publ) | Synagis | 1998-06-19 |
NCAGE Code | A261N | SWEDISH ORPHAN BIOVITRUM AB (PUBL) |
NCAGE Code | SGP97 | SWEDISH ORPHAN BIOVITRUM AB (PUBL) |
CAGE Code | SGP97 | SWEDISH ORPHAN BIOVITRUM AB (PUBL) |
CAGE Code | A261N | SWEDISH ORPHAN BIOVITRUM AB (PUBL) |
SEC | 0001789731 | Swedish Orphan Biovitrum AB (publ) of SWEDEN |